These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29028741)

  • 61. Conditions for confounding of the risk ratio and of the odds ratio.
    Boivin JF; Wacholder S
    Am J Epidemiol; 1985 Jan; 121(1):152-8. PubMed ID: 3964989
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Five-Region Hypothesis Test for Exposure-Disease Associations.
    Shih HY; Lee WC
    Sci Rep; 2017 Jul; 7(1):5131. PubMed ID: 28698548
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The epidemiologic approach to studies of association between HLA and disease. II. Estimation of absolute risks, etiologic and preventive fraction.
    Green A
    Tissue Antigens; 1982 Apr; 19(4):259-68. PubMed ID: 7101270
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Estimability and estimation in case-referent studies.
    Miettinen O
    Am J Epidemiol; 1976 Feb; 103(2):226-35. PubMed ID: 1251836
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Continuous outcome measures: conundrums and conversions contributing to clinical application.
    Mayer M
    BMJ Evid Based Med; 2019 Aug; 24(4):133-136. PubMed ID: 30837230
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Common pitfalls in statistical analysis: Absolute risk reduction, relative risk reduction, and number needed to treat.
    Ranganathan P; Pramesh CS; Aggarwal R
    Perspect Clin Res; 2016; 7(1):51-3. PubMed ID: 26952180
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Calculating risk and prevalence ratios and differences in R: developing intuition with a hands-on tutorial and code.
    Yorlets RR; Lee Y; Gantenberg JR
    Ann Epidemiol; 2023 Oct; 86():104-109. PubMed ID: 37572803
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prevalence and incidence – what’s the difference?
    Hinneburg I
    Med Monatsschr Pharm; 2017 Mar; 40(3):124-6. PubMed ID: 29952483
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Department of Epidemiology and Public Health, School of Medicine, Yale University, New Haven, CT.
    Morgenstern H; Kleinbaum DG; Kupper LL
    Int J Epidemiol; 1980 Mar; 9(1):97-104. PubMed ID: 7419335
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Conceptual problems in the definition and interpretation of attributable fractions.
    Greenland S; Robins JM
    Am J Epidemiol; 1988 Dec; 128(6):1185-97. PubMed ID: 3057878
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Analyzing the Relationship between Cohort and Case-Control Study Results Based on Model for Multiple Pathogenic Factors.
    Liu H
    Comput Math Methods Med; 2019; 2019():7507043. PubMed ID: 32082409
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Criteria for selection of decedent versus living controls in a mortality case-control study.
    Calle EE
    Am J Epidemiol; 1984 Oct; 120(4):635-42. PubMed ID: 6475931
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Unidirectional multiple comparisons of Poisson rates.
    Suissa S; Salmi R
    Stat Med; 1989 Jun; 8(6):757-64. PubMed ID: 2787523
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of your results: Beyond the relative risk.
    Siegerink B; Rohmann JL
    Res Pract Thromb Haemost; 2018 Oct; 2(4):653-657. PubMed ID: 30349882
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Distributional interaction: Interpretational problems when using incidence odds ratios to assess interaction.
    Campbell UB; Gatto NM; Schwartz S
    Epidemiol Perspect Innov; 2005; 2():1. PubMed ID: 15745447
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Dynamic path analysis on life course epidemiology].
    Tian ZW; Zeng GY; Wu SL; Huang LT; Wang BZ; Tan HZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jan; 39(1):86-89. PubMed ID: 29374903
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevalence odds ratio versus prevalence ratio: choice comes with consequences.
    Tamhane AR; Westfall AO; Burkholder GA; Cutter GR
    Stat Med; 2016 Dec; 35(30):5730-5735. PubMed ID: 27460748
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reporting only relative effect measures was potentially misleading: some good practices for improving the soundness of epidemiological results.
    Novelli M; Baldi Antognini A; Boffetta P; Ioannidis JP; Spatari G; Violante FS
    J Clin Epidemiol; 2021 Sep; 137():195-199. PubMed ID: 33894329
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Epidemiology applied to the investigation of infant health determinants: basic concepts and methods].
    Fuchs SC
    J Pediatr (Rio J); 1995; 71(3):132-8. PubMed ID: 14689010
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dichotomization: 2 x 2 (x2 x 2 x 2...) categories: infinite possibilities.
    Heavner KK; Phillips CV; Burstyn I; Hare W
    BMC Med Res Methodol; 2010 Jun; 10():59. PubMed ID: 20573189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.